Dyax Shares Jump On Drug Study, FDA Fast-track Status
March 31, 2015 at 16:55 PM EDT
Shares of Dyax Corp. jumped in the extended session Tuesday after the biotech reported promising results for its treatment of a rare inflammatory condition.
